Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer

被引:52
作者
Kandula, Tejaswi [1 ,2 ]
Farrar, Michelle A. [1 ,2 ]
Kiernan, Matthew C. [3 ]
Krishnan, Arun V. [4 ]
Goldstein, David [4 ]
Horvath, Lisa [5 ,6 ,7 ]
Grimison, Peter [5 ,6 ]
Boyle, Frances [6 ,8 ]
Baron-Hay, Sally [9 ]
Park, Susanna B. [3 ,4 ]
机构
[1] Univ New South Wales, Sch Womens & Childrens Hlth, Discipline Pediat, UNSW Med, Randwick, NSW, Australia
[2] Sydney Childrens Hosp, Dept Neurol, Randwick, NSW, Australia
[3] Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, 94 Mallett St, Sydney, NSW, Australia
[4] Univ New South Wales, Prince Wales Clin Sch, UNSW Med, Randwick, NSW, Australia
[5] Chris OBrien Lifehouse, Sydney, NSW, Australia
[6] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[7] Royal Prince Alfred Hosp, Dept Oncol, Camperdown, NSW, Australia
[8] Mater Hosp, Patricia Ritchie Ctr Canc Care & Res, Sydney, NSW, Australia
[9] Royal North Shore Hosp, Dept Oncol, St Leonards, NSW, Australia
基金
英国医学研究理事会;
关键词
Chemotherapy induced peripheral; neuropathy; Cancer survivorship; Cancer late effects; Neurophysiology; Patient reported outcomes; INDUCED PERIPHERAL NEUROPATHY; OXALIPLATIN-INDUCED NEUROPATHY; QUALITY-OF-LIFE; CISPLATIN-INDUCED NEUROPATHY; ACUTE LYMPHOBLASTIC-LEUKEMIA; GUILLAIN-BARRE-SYNDROME; MARIE-TOOTH DISEASE; THALIDOMIDE NEUROPATHY; MULTIPLE-MYELOMA; VINCRISTINE NEUROPATHY;
D O I
10.1016/j.clinph.2017.04.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chemotherapy induced peripheral neuropathy (CIPN) is a significant toxicity of cancer treatment, with the potential to affect long-term function and quality of life in cancer survivors. There remains a lack of consensus around optimal assessment techniques. While current approaches to CIPN assessment are focused on clinical grading scales, it is becoming increasingly evident that a more comprehensive multimodal assessment package is necessary to accurately characterise the impact of CIPN as well as gauge the utility of neuroprotective mechanisms. Neurophysiological techniques provide objective biomarkers and may enable early detection of toxicity while patient reported outcomes are necessary to determine the significance of symptoms to individual patients. In addition to providing an objective assessment, clinical neurophysiological techniques provide important insights into the contributory pathophysiological mechanisms of CIPN with different chemotherapy agents. There is a paucity of implementation of these techniques in the clinical trial setting. The present Review aims to facilitate the use of neurophysiological studies as part of comprehensive assessment packages for the monitoring of CIPN by summarising current understanding of neurophysiological changes that underlie the development of neuropathy, clinical presentations and patient reported outcomes as well as advantages and limitations of current techniques for the neurophysiological assessment of CIPN. (C) 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1166 / 1175
页数:10
相关论文
共 143 条
[1]  
[Anonymous], EUR J CANC CARE
[2]   Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy [J].
Argyriou, A. A. ;
Polychronopoulos, P. ;
Koutras, A. ;
Xiros, N. ;
Petsas, T. ;
Argyriou, K. ;
Kalofonos, H. P. ;
Chroni, E. .
EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (03) :231-237
[3]   Paclitaxel plus carboplatin-induced peripheral neuropathy - A prospective clinical and electrophysiological study in patients suffering from solid malignancies [J].
Argyriou, AA ;
Polychronopoulos, P ;
Iconomou, G ;
Koutras, A ;
Kalofonos, HP ;
Chroni, E .
JOURNAL OF NEUROLOGY, 2005, 252 (12) :1459-1464
[4]   Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted? [J].
Argyriou, AA ;
Polychronopoulos, P ;
Koutras, A ;
Iconomou, G ;
Iconomou, A ;
Kalofonos, HP ;
Chroni, E .
SUPPORTIVE CARE IN CANCER, 2005, 13 (08) :647-651
[5]   Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer [J].
Argyriou, Andreas A. ;
Polychronopoulos, Panagiotis ;
Iconomou, Gregoris ;
Koutras, Angelos ;
Makatsoris, Thomas ;
Gerolymos, Miltiadis K. ;
Gourzis, Philippos ;
Assimakopoulos, Konstantinos ;
Kalofonos, Haralabos P. ;
Chroni, Elisabeth .
ACTA ONCOLOGICA, 2007, 46 (08) :1131-1137
[6]   Clinical pattern and associations of oxaliplatin acute neurotoxicity [J].
Argyriou, Andreas A. ;
Cavaletti, Guido ;
Briani, Chiara ;
Velasco, Roser ;
Bruna, Jordi ;
Campagnolo, Marta ;
Alberti, Paola ;
Bergamo, Francesca ;
Cortinovis, Diego ;
Cazzaniga, Marina ;
Santos, Cristina ;
Papadimitriou, Konstantinos ;
Kalofonos, Haralabos P. .
CANCER, 2013, 119 (02) :438-444
[7]   Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings [J].
Augusto, Caraceni ;
Pietro, Miccoli ;
Cinzia, Martini ;
Sergio, Curzi ;
Sara, Cresta ;
Luca, Gianni ;
Scaioli, Vidmer .
JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (01) :89-99
[8]   Acute Onset Flaccid Quadriparesis in Pediatric Non-Hodgkin Lymphoma: Vincristine Induced or Guillain-Barre Syndrome? [J].
Bahl, Ankur ;
Chakrabarty, Biswaroop ;
Gulati, Sheffali ;
Raju, K. N. Vykunta ;
Raja, Ali ;
Bakhshi, Sameer .
PEDIATRIC BLOOD & CANCER, 2010, 55 (06) :1234-1235
[9]   Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity [J].
Basso, Michele ;
Modoni, Anna ;
Spada, Daniele ;
Cassano, Alessandra ;
Schinzari, Giovanni ;
Lo Monaco, Mauro ;
Quaranta, Davide ;
Tonali, Pietro Attilio ;
Barone, Carlo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) :1179-1187
[10]   Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients [J].
Bastuji-Garin, S ;
Ochonisky, S ;
Bouche, P ;
Gherardi, RK ;
Duguet, C ;
Djerradine, Z ;
Poli, F ;
Revuz, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) :1020-1026